2.23
Serina Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
2.45
FY23:
7.62
FY24:
5.68
FY25:
6.08
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.92
FY22:
0.79
FY23:
1.35
FY24:
1.05
FY25:
0.87
Total assets
Change from FY21 to FY25
millions USD
FY21:
3.15
FY22:
3.24
FY23:
8.97
FY24:
6.72
FY25:
6.95
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.97
FY22:
10.1
FY23:
1.41
FY24:
2.37
FY25:
3.56
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.06
FY22:
10.5
FY23:
3.45
FY24:
3.85
FY25:
3.43
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.8
FY22:
−17.2
FY23:
−32.3
FY24:
0.64
FY25:
−0.04
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
3.20
FY22:
3.34
FY23:
–
FY24:
6.86
FY25:
6.95
All amounts in millions USD